Sheila M. Dowd

1.1k total citations
36 papers, 735 citations indexed

About

Sheila M. Dowd is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Sheila M. Dowd has authored 36 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 8 papers in Clinical Psychology. Recurrent topics in Sheila M. Dowd's work include Electroconvulsive Therapy Studies (9 papers), Treatment of Major Depression (9 papers) and Schizophrenia research and treatment (8 papers). Sheila M. Dowd is often cited by papers focused on Electroconvulsive Therapy Studies (9 papers), Treatment of Major Depression (9 papers) and Schizophrenia research and treatment (8 papers). Sheila M. Dowd collaborates with scholars based in United States, Japan and Germany. Sheila M. Dowd's co-authors include Philip G. Janicak, Rajiv P. Sharma, Danesh Alam, Brian Martis, Cherise Rosen, Mary Jane Strong, Jack Krasuski, Marlos A. G. Viana, Shirlene Sampson and Mark H. Pollack and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Sheila M. Dowd

34 papers receiving 696 citations

Peers

Countries citing papers authored by Sheila M. Dowd

Since Specialization

Citations

This map shows the geographic impact of Sheila M. Dowd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila M. Dowd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila M. Dowd more than expected).

Fields of papers citing papers by Sheila M. Dowd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila M. Dowd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila M. Dowd. The network helps show where Sheila M. Dowd may publish in the future.

Co-authorship network of co-authors of Sheila M. Dowd

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila M. Dowd. A scholar is included among the top collaborators of Sheila M. Dowd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila M. Dowd. Sheila M. Dowd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring study dropout in drug trials for adults with PTSD: insights from a conventional and individual participant data meta-analysis 2025 ·European journal of psychotraumatology ·(unknown), (unknown), Marit Sijbrandij, Eirini Karyotaki, Pim Cuijpers, Jonathan I. Bisson, Kathleen T. Brady, Sheila M. Dowd, Boadie W. Dunlop, Mark H. Pollack, (unknown), Soraya Seedat	1
2	Psychologists’ Well-Being, Stressors, and Practices in Academic Health Centers: A Peri-Pandemic Update 2025 ·Journal of Clinical Psychology in Medical Settings ·Amy M. Williams, (unknown), (unknown), Michelle T. Jesse, Sheila M. Dowd, John A. Yozwiak, William N. Robiner	0
3	Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT 2023 ·Journal of Psychiatric Research ·(unknown), Hayley E. Fitzgerald, David Rosenfield, Joseph K. Carpenter, Santiago Papini, (unknown), Sheila M. Dowd, Stefan G. Hofmann, Mark H. Pollack, Jasper A. J. Smits, Michael W. Otto	1
4	What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder 2023 ·Behaviour Research and Therapy ·Charles T. Taylor, (unknown), Sheila M. Dowd, (unknown), Stefan G. Hofmann, Michael W. Otto, Mark H. Pollack, Jasper A. J. Smits	7
5	The Eyes Have It: Psychotherapy in the Era of Masks 2022 ·Journal of Clinical Psychology in Medical Settings ·(unknown), Sheila M. Dowd, (unknown), (unknown)	6
6	Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia 2020 ·World Journal of Psychiatry ·Sheila M. Dowd, Alyson K. Zalta, Helen J. Burgess, (unknown), (unknown), Mark H. Pollack	9
7	Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder 2019 ·PLoS ONE ·Stefan G. Hofmann, Santiago Papini, Joseph K. Carpenter, Michael W. Otto, David Rosenfield, (unknown), Sheila M. Dowd, (unknown), Sara M. Witcraft, Mark H. Pollack, Jasper A. J. Smits	16
8	d-cycloserine augmentation of exposure therapy: Review and new directions 2016 ·Quality in primary care ·Michael Davis, Sara M. Witcraft, Jasper A. J. Smits, Sheila M. Dowd, Mark H. Pollack, David Rosenfield, Michael W. Otto, Stefan G. Hofmann	1
9	RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER 2016 ·Depression and Anxiety ·Michael W. Otto, Mark H. Pollack, Sheila M. Dowd, Stefan G. Hofmann, Godfrey D. Pearlson, Kristin L. Szuhany, Ralitza Gueorguieva, John H. Krystal, Naomi M. Simon, David F. Tolin	19
10	Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study 2015 ·Brain stimulation ·Noah S. Philip, David L. Dünner, Sheila M. Dowd, Scott T. Aaronson, David G. Brock, Linda L. Carpenter, Mark A. Demitrack, (unknown), Philip G. Janicak, Mark S. George	53
11	Adjunctive Use of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents 2011 ·The Journal of Clinical Psychiatry ·Christopher A. Wall, Paul E. Croarkin, Leslie Sim, Mustafa M. Husain, Philip G. Janicak, F. Andrew Kozel, Graham J. Emslie, Sheila M. Dowd, Shirlene Sampson	67
12	Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study 2010 ·Brain stimulation ·Philip G. Janicak, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene Sampson, William M. McDonald, Lauren B. Marangell, (unknown), W. Vaughn McCall, James Kimball, John P. O’Reardon, Colleen Loo, (unknown), Andrew D. Krystal, William Gilmer, Sheila M. Dowd, Mark A. Demitrack, Alan F. Schatzberg	117
13	Paliperidone ER: Reformulated Antipsychotic for Schizophrenia Tx; Risperidone's Metabolite Behaves Well but Differently in Once-Daily Delivery 2007 ·Current psychiatry ·Jeffrey Rado, Sheila M. Dowd, Philip G. Janicak	1
14	Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam 2003 ·Analytical and Bioanalytical Chemistry ·Adam Negrusz, (unknown), Christine Moore, Sheila M. Dowd, Mary Jane Strong, Philip G. Janicak	16
15	Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression 2003 ·Clinical Neurophysiology ·Brian Martis, Danesh Alam, Sheila M. Dowd, S. Kristian Hill, Rajiv P. Sharma, Cherise Rosen, Neil H. Pliskin, Eileen Martin, (unknown), Philip G. Janicak	98
16	Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial 2002 ·Biological Psychiatry ·Philip G. Janicak, Sheila M. Dowd, Brian Martis, Danesh Alam, (unknown), Jack Krasuski, Mary Jane Strong, Rajiv P. Sharma, Cherise Rosen, Marlos A. G. Viana	145
17	A Double-Blind, Randomized, Prospective Evaluation of the Efficacy and Safety of Risperidone Versus Haloperidol in the Treatment of Schizoaffective Disorder 2001 ·Journal of Clinical Psychopharmacology ·P G Janicak, Paul E. Keck, John M. Davis, John Kasckow, Karen C. Tugrul, Sheila M. Dowd, Jane Strong, Rajiv P. Sharma, Stephen M. Strakowski	32
18	Age of illness onset and schizophrenic symptomatology during an inpatient washout period 1996 ·Schizophrenia Research ·Rajiv P. Sharma, Sheila M. Dowd, John M. Davis, Philip G. Janicak	4
19	Random assignment to three haloperidol plasma levels for acute psychosis 1994 ·Biological Psychiatry ·Philip G. Janicak, (unknown), Rajiv P. Sharma, (unknown), Sheila M. Dowd, (unknown), J. M. Davis	4
20	EFFECTS OF UNILATERAL-NONDOMINANT VS. BILATERAL ECT ON MEMORY AND DEPRESSION: A PRELIMINARY REPORT 1992 ·Clinical Neuropharmacology ·(unknown), Ravi Sharma, (unknown), Sheila M. Dowd, (unknown), J M Davis	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact